Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

Abstract

OBJECTIVE To study the pharmacokinetic and pharmacodynamic profile of insulin aspart (a new fast-acting human insulin analog) after subcutaneous administration in the deltoid, abdominal, and thigh sites and to compare this profile with regular human insulin (Novolin; Novo Nordisk A/S, Copenhagen). RESEARCH DESIGN AND METHODS A total of 20 healthy subjects… (More)

Topics

Cite this paper

@article{Mudaliar1999InsulinA, title={Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.}, author={Sundar R D Mudaliar and Fanny Lindberg and M. Gordon Joyce and P Beerdsen and Poul Strange and Ai-Ling Lin and Robert R. Henry}, journal={Diabetes care}, year={1999}, volume={22 9}, pages={1501-6} }